Floatz logo

Romidepsin

Advanced Cancers

M.D. Anderson Cancer CenterSmall moleculePhase 2Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Advanced Cancers cohort.

Asset / SponsorPhaseRating
Vitamin B6
M.D. Anderson Cancer Center
Phase 4BB
Lipitor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2/3BB
Azacitidine
AbbVie
Phase 3BB
cc-5013
CStone Pharmaceuticals
Phase 2BB
Vorinostat
M.D. Anderson Cancer Center
Phase 1/2B

View all 20 →

Same molecule, other indications

Romidepsin is also rated in:

Myelodysplastic/Myeloproliferative DiseasesDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Mycosis Fungoides/Sezary SyndromeDormant
BBB
Indicative ·
75 / 100
View asset →
Multiple Myeloma and Plasma Cell NeoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →